Cited 56 time in
Ferulic acid attenuates the cerebral ischemic injury-induced decrease in peroxiredoxin-2 and thioredoxin expression
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sung, Jin-Hee | - |
| dc.contributor.author | Gim, Sang-Ah | - |
| dc.contributor.author | Koh, Phil-Ok | - |
| dc.date.accessioned | 2022-12-26T23:06:55Z | - |
| dc.date.available | 2022-12-26T23:06:55Z | - |
| dc.date.issued | 2014-04-30 | - |
| dc.identifier.issn | 0304-3940 | - |
| dc.identifier.issn | 1872-7972 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/19031 | - |
| dc.description.abstract | Ferulic acid, a phenolic phytochemical compound found in various plants, has a neuroprotective effect through its anti-oxidant and anti-inflammation functions. Peroxiredoxin-2 and thioredoxin play a potent neuroprotective function against oxidative stress. We investigated whether ferulic acid regulates peroxiredoxin-2 and thioredoxin. levels in cerebral ischemia. Sprague-Dawley rats (male, 210-230 g) were treated with vehicle or ferulic acid (100 mg/kg) after middle cerebral artery occlusion (MCAO), and cerebral cortex tissues were collected 24 h after MCAO. Decreases in peroxiredoxin-2 and thioredoxin levels were elucidated in MCAO-operated animals using a proteomics approach. We found that ferulic acid treatment prevented the MCAO-induced decrease in the expression of peroxiredoxin-2 and thioredoxin. RT-PCR and Western blot analyses confirmed that ferulic acid treatment attenuated the MCAO-induced decrease in peroxiredoxin-2 and thioredoxin levels. Moreover, immunoprecipitation analysis showed that the interaction between thioredoxin and apoptosis signal-regulating kinase 1 (ASK1) decreased during MCAO, whereas ferulic acid prevented the MCAO-induced decrease in this interaction. Our findings suggest that ferulic acid plays a neuroprotective role by attenuating injury-induced decreases in peroxiredoxin-2 and thioredoxin levels in neuronal cell injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER IRELAND LTD | - |
| dc.title | Ferulic acid attenuates the cerebral ischemic injury-induced decrease in peroxiredoxin-2 and thioredoxin expression | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.neulet.2014.02.040 | - |
| dc.identifier.scopusid | 2-s2.0-84896088080 | - |
| dc.identifier.wosid | 000335613800018 | - |
| dc.identifier.bibliographicCitation | NEUROSCIENCE LETTERS, v.566, pp 88 - 92 | - |
| dc.citation.title | NEUROSCIENCE LETTERS | - |
| dc.citation.volume | 566 | - |
| dc.citation.startPage | 88 | - |
| dc.citation.endPage | 92 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
| dc.subject.keywordPlus | ANTIOXIDANT ACTIVITY | - |
| dc.subject.keywordPlus | BRAIN | - |
| dc.subject.keywordPlus | OVEREXPRESSION | - |
| dc.subject.keywordPlus | MICE | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | PREVENTS | - |
| dc.subject.keywordPlus | ESTERS | - |
| dc.subject.keywordAuthor | Ferulic acid | - |
| dc.subject.keywordAuthor | Neuroprotection | - |
| dc.subject.keywordAuthor | Peroxiredoxin-2 | - |
| dc.subject.keywordAuthor | Thioredoxin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
